000			04082nam a22006737a 4500
008			240807s20242024 xxu||||| |||| 00| 0 eng d
022			_a1051-0443
024			_aS1051-0443(24)00193-3 [pii]
040			_aOvid MEDLINE(R)
099			_a38789205
245			_aIntranodal Lymphangiography and Embolization for Management of Iatrogenic Chylous Ascites after Oncological Surgery.
251			_aJournal of Vascular & Interventional Radiology. 35(6):883-889, 2024 Jun.
252			_aJ Vasc Interv Radiol. 35(6):883-889, 2024 Jun.
253			_aJournal of vascular and interventional radiology : JVIR
260			_c2024
260			_fFY2024
260			_p2024 Jun
265			_sppublish
265			_tMEDLINE
266			_d2024-08-07
266			_z2024/05/24 20:57
501			_aAvailable online through MWHC library: 2002 - 2006, Available in print through MWHC library: 1999 - 2006
520			_aCONCLUSIONS: INL with or without LE is a safe minimally invasive tool that can help patients with chylous ascites after oncologic surgery who failed conservative treatment avoid more invasive interventions. Copyright © 2024 SIR. Published by Elsevier Inc. All rights reserved.
520			_aMATERIALS AND METHODS: Retrospective review of records of patients who underwent INL with or without LE from January 2017 to June 2022 was performed. Adult patients with chylous ascites after oncologic surgery referred to interventional radiology after failure of conservative treatment were included. Thirty-nine patients who underwent 55 procedures were included (34 males and 5 females). Data on patient demographics, procedural technique, outcomes, and follow-up were collected. Descriptive statistics were used to illustrate technical success, clinical success, and adverse events. Univariate logistic regression analysis was performed to evaluate factors predicting clinical success.
520			_aPURPOSE: To investigate the safety and effectiveness of intranodal lymphangiography (INL) and lymphatic embolization (LE) in management of chylous ascites after oncologic surgery.
520			_aRESULTS: INL was technically successful in 54 of 55 procedures (98%; 95% confidence interval [CI], 90%-100%). A lymphatic leak was identified in 40 procedures, and LE was attempted in 36. LE was technically successful in 33 of the 36 procedures (92%; 95% CI, 78%-98%). Clinical success, defined as resolution of ascites with no need for peritoneovenous shunt placement or additional surgery, was achieved in 22 of 39 patients (56%; 95% CI, 40%-72%). Clinical success was achieved in 18 patients after 1 procedure, and patients who required repeat procedures were less likely to achieve clinical success (odds ratio, 0.16; 95% CI, 0.04-0.66; P = .012). Four grade 1 procedural adverse events were recorded.
546			_aEnglish
650			_a*Chylous Ascites
650			_a*Embolization, Therapeutic
650			_a*Iatrogenic Disease
650			_a*Lymphography
650			_a*Predictive Value of Tests
650			_aAdult
650			_aAged
650			_aAged, 80 and over
650			_aChylous Ascites/dg [Diagnostic Imaging]
650			_aChylous Ascites/et [Etiology]
650			_aChylous Ascites/th [Therapy]
650			_aEmbolization, Therapeutic/ae [Adverse Effects]
650			_aFemale
650			_aHumans
650			_aMale
650			_aMiddle Aged
650			_aNeoplasms/co [Complications]
650			_aNeoplasms/su [Surgery]
650			_aRadiography, Interventional/ae [Adverse Effects]
650			_aRetrospective Studies
650			_aRisk Factors
650			_aTime Factors
650			_aTreatment Outcome
650			_zAutomated
651			_aMedStar Medical Group
656			_aRadiology
657			_aJournal Article
700			_aAly, Ahmed K _bMMG
790			_aAly AK, Santos E, Fung J, Maybody M, Youssef EW, Petre EN, Gonzalez-Aguirre AJ, Moussa AM
856			_uhttps://dx.doi.org/10.1016/j.jvir.2024.02.015 _zhttps://dx.doi.org/10.1016/j.jvir.2024.02.015
942			_cART _dArticle
999			_c14605 _d14605